Cargando…

Current therapies and new developments in NASH

Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver disease. There has been important progress in the field in recent years and the complexity of the pathophysiology of NASH is better understood. Multiple non-invasive circulating and imaging biomarkers have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dufour, Jean-François, Anstee, Quentin M, Bugianesi, Elisabetta, Harrison, Stephen, Loomba, Rohit, Paradis, Valerie, Tilg, Herbert, Wong, Vincent Wai-Sun, Zelber-sagi, Shira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Recent Advances in Clinical Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484366/ https://www.ncbi.nlm.nih.gov/pubmed/35710299 http://dx.doi.org/10.1136/gutjnl-2021-326874

Ejemplares similares

Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
por: Dufour, Jean-François, et al.
Publicado: (2020)

From the origin of NASH to the future of metabolic fatty liver disease
por: Geier, Andreas, et al.
Publicado: (2021)

Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention
por: Romero-Gómez, Manuel, et al.
Publicado: (2023)

Calprotectin: from biomarker to biological function
por: Jukic, Almina, et al.
Publicado: (2021)

Gut microbiome and health: mechanistic insights
por: de Vos, Willem M, et al.
Publicado: (2022)

Natural history of NASH
por: Armandi, Angelo, et al.
Publicado: (2021)

Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management
por: Leung, T.F, et al.
Publicado: (2003)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

Applications of dual energy CT in clinical practice: A pictorial essay
por: Sanghavi, Parang S, et al.
Publicado: (2019)

MR-guided focused ultrasound surgery: A novel non-invasive technique in the treatment of adenomyosis –18 month's follow-up of 12 cases
por: Dev, Bhawna, et al.
Publicado: (2019)

Mechanisms of rhinovirus-induced asthma
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2004)

Modern diagnosis of GERD: the Lyon Consensus
por: Gyawali, C Prakash, et al.
Publicado: (2018)

Intestinal microbiota in functional bowel disorders: a Rome foundation report
por: Simrén, Magnus, et al.
Publicado: (2013)

Symptomatic reflux disease: the present, the past and the future
por: Boeckxstaens, Guy, et al.
Publicado: (2014)

Expert opinions and scientific evidence for colonoscopy key performance indicators
por: Rees, Colin J, et al.
Publicado: (2016)

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
por: Lawler, Mark, et al.
Publicado: (2018)

Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review
por: Bettenworth, Dominik, et al.
Publicado: (2019)

Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
por: Waldman, Scott A, et al.
Publicado: (2018)

Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017)

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Machine learning in GI endoscopy: practical guidance in how to interpret a novel field
por: van der Sommen, Fons, et al.
Publicado: (2020)

Big data in IBD: big progress for clinical practice
por: Seyed Tabib, Nasim Sadat, et al.
Publicado: (2020)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
por: Chapelle, Nicolas, et al.
Publicado: (2020)

Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management
por: Misselwitz, Benjamin, et al.
Publicado: (2019)

DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments
por: Gottlieb, Klaus, et al.
Publicado: (2021)

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
por: Pinter, Matthias, et al.
Publicado: (2021)

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
por: Urban, Stephan, et al.
Publicado: (2021)

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
por: van Baar, Annieke C G, et al.
Publicado: (2021)

Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022)

Understanding the role of the gut in undernutrition: what can technology tell us?
por: Thompson, Alex J, et al.
Publicado: (2021)

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
por: Lin, Simeng, et al.
Publicado: (2022)

Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease
por: Rimola, Jordi, et al.
Publicado: (2022)

Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders
por: Vanuytsel, Tim, et al.
Publicado: (2023)

SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
por: Luxenburger, Hendrik, et al.
Publicado: (2023)

Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD
por: Marjot, Thomas, et al.
Publicado: (2023)

Multicytokine-producing CD4(+) T cells characterize the livers of patients with NASH
por: Woestemeier, Anna, et al.
Publicado: (2023)

Using ultrasound in ICU
por: Wong, Adrian, et al.
Publicado: (2023)

Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
por: Dongiovanni, Paola, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h39amv1br0i9cekk3mf7qq20jb